Skip to content
ENGLISH
FRANCAIS
Solutions
Drug Development Journey
Services Overview
Clinical Trial Operations
Protocol Development and Study Design
Feasibility and Study Start Up
Patient Recruitment
Project Management
Clinical Operations
Centralized Monitoring
Decentralized Clinical Trials (DCT)
Centralized eTMF
Medical Services
Government and Public Health Services
Biometrics
Biostatistics and Statistical Programming
Biostatistical Consulting
Clinical Data Management
Clinical Programming and Data Science
Clinical Pharmacology Modeling Simulation
Clinical Pharmacology Integrated Drug Development
Model Informed Dose & Drug Development (MIDD)
Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
DMPK and Translational Discovery and Development
Regulatory and Drug Development Consulting
Clinical Strategy
Nonclinical
Chemistry, Manufacturing, and Controls (CMC)
Regulatory Affairs
GxP Strategy Consulting
Publishing and Submissions
Medical Writing
Therapeutic Expertise
Therapeutic Expertise Overview
By Subject
Oncology and Hematology
Rare Diseases and Orphan Drugs
Infectious Disease and Vaccine
Cell and Gene Therapy
Central Nervous System
Autoimmune and Inflammation
Allergy and Asthma
By Phase
Company
About Us
History
News
Events
Leadership Team
Mission, Vision, Values
Resources
Resource Library
Blogs
Case Studies
Podcasts
Webinar
White Paper
Careers
Careers Overview
Job Listings
CRA Academy and Fellows Programs
Contact Us
Contact Us
Request for Proposal / Information
Menu
Solutions
Drug Development Journey
Services Overview
Clinical Trial Operations
Protocol Development and Study Design
Feasibility and Study Start Up
Patient Recruitment
Project Management
Clinical Operations
Centralized Monitoring
Decentralized Clinical Trials (DCT)
Centralized eTMF
Medical Services
Government and Public Health Services
Biometrics
Biostatistics and Statistical Programming
Biostatistical Consulting
Clinical Data Management
Clinical Programming and Data Science
Clinical Pharmacology Modeling Simulation
Clinical Pharmacology Integrated Drug Development
Model Informed Dose & Drug Development (MIDD)
Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
DMPK and Translational Discovery and Development
Regulatory and Drug Development Consulting
Clinical Strategy
Nonclinical
Chemistry, Manufacturing, and Controls (CMC)
Regulatory Affairs
GxP Strategy Consulting
Publishing and Submissions
Medical Writing
Therapeutic Expertise
Therapeutic Expertise Overview
By Subject
Oncology and Hematology
Rare Diseases and Orphan Drugs
Infectious Disease and Vaccine
Cell and Gene Therapy
Central Nervous System
Autoimmune and Inflammation
Allergy and Asthma
By Phase
Company
About Us
History
News
Events
Leadership Team
Mission, Vision, Values
Resources
Resource Library
Blogs
Case Studies
Podcasts
Webinar
White Paper
Careers
Careers Overview
Job Listings
CRA Academy and Fellows Programs
Contact Us
Contact Us
Request for Proposal / Information
Search
Search
Search
Search
Home
|
Company
|
News
News
Filter By Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
February 20, 2024
Investments Report with Dr. Mark A. Goldberg
Read More
August 28, 2023
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines
Read More
June 20, 2023
Allucent Selects THREAD To Power Patient Direct Trials Offering
Read More
May 23, 2023
Allucent Launches Decentralized Clinical Trial Solution at 2023 World Orphan Drug Congress
Read More
March 14, 2023
Allucent Appoints Alexander J. MacDonald as Vice President of Model-Informed Drug Development
Read More
February 27, 2023
Allucent Appoints Life Science Veteran, Bob Millham, to Head Newly Formed Customer Engagement Unit
Read More
February 13, 2023
Allucent Appoints Lisa Benincosa as Senior Vice President of Clinical Pharmacology Strategy
Read More
January 24, 2023
Allucent Is Now Great Place To Work Certified
Read More
January 10, 2023
Allucent Appoints Alexander Berg as Vice President of Clinical Pharmacology Development and Operations
Read More
December 12, 2022
Allucent Appoints Sugato De as Vice President of Regulatory Strategy and Head of Medical Technology
Read More
October 18, 2022
Allucent Expands Presence in India and Deepens World-Class Operational Functions with Opening of New Office in Chennai
Read More
September 6, 2022
Allucent Chairman and CEO Mark A. Goldberg Honored by PharmaVoice as One of the Year’s 100 Most Inspiring People in Life Sciences
Read More
August 22, 2022
Allucent Appoints Steffany Cox as Chief Marketing Officer
Read More
June 14, 2022
Allucent Appoints President of Clinical Pharmacology, Modeling and Simulation
Read More
May 2, 2022
CATO SMS is Now Allucent
Read More
January 5, 2022
CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER
Read More
January 5, 2022
CATO SMS and Pharm-Olam Merge to Create Global Biopharmaceutical Services Leader
Read More
December 8, 2021
CATO SMS Appoints Regulatory Strategy Leader in Pharmacology and Toxicology
Read More
September 30, 2021
CATO SMS Appoints Vice President of Regulatory Strategy Cell and Gene Therapy
Read More
September 13, 2021
CATO SMS Appoints Dr. Teresa Nunes Chief Medical Officer
Read More
September 2, 2021
CATO SMS Appoints Vice President of Regulatory Strategy
Read More
July 7, 2021
CATO SMS Appoints President of Clinical Trial Operations
Read More
June 9, 2021
CATO SMS Appoints Regulatory Strategy Leader
Read More
May 26, 2021
CATO SMS Acquires Nuventra To Expand Drug Development Offering Into Clinical Pharmacology
Read More
May 20, 2021
Pharm-Olam Enrolling UK Volunteers for Phase 3 Valneva COVID-19 Vaccine Study
Read More
March 3, 2021
CATO SMS Announces Consulting Leadership Appointment
Read More
January 19, 2021
US Department of Defense selects Pharm-Olam as CRO for Adalimumab COVID Therapeutic Trial
Read More
November 24, 2020
LAVA Therapeutics signed agreement with CATO SMS to conduct its Phase I/IIa trial with T-cell engager LAVA-051 in hematologic malignancies
Read More
October 8, 2020
BARDA Selects Pharm-Olam to Support Clinical Trial Planning & Execution for up to 5 Years
Read More
September 29, 2020
Double Bond Pharmaceutical concludes Key Opinion Leader (KOL) meeting, an important milestone for SI-053 Phase 1 clinical study
Read More
September 23, 2020
Pharm-Olam Selected as a CRO for Department of Defense Support to Operation Warp Speed Vaccine Trials, Partnering with Geneva Foundation
Read More
September 15, 2020
CATO SMS Acquires Array Biostatistics
Read More
September 2, 2020
CATO SMS Unveils New Brand
Read More
June 24, 2020
Pharm-Olam Positioning for Growth Trajectory
Read More
June 16, 2020
Pharm-Olam Launches New Protocol Optimization Service
Read More
May 26, 2020
Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers
Read More
May 19, 2020
CATO SMS Signs Agreement with InteRNA to Facilitate Phase I Solid Tumor Trial
Read More
April 29, 2020
Pharm-Olam recognized by 2020 CRO Leadership Awards second year in a row
Read More
April 27, 2020
Accredited Internationally Qualified Clinical Research Auditor Standard Launches
Read More
March 26, 2020
Pharm-Olam selected to support Revive Therapeutics development of Bucillamine for COVID-19
Read More
March 23, 2020
Pharm-Olam’s Response to COVID-19: Safety, Community, Research
Read More
March 16, 2020
COVID-19 CATO SMS OPERATIONS UPDATE
Read More
October 28, 2019
CATO Research Announces Merger With SMS-Oncology
Read More
October 9, 2019
Pharm-Olam names new CEO, Dr. Robert Davie
Read More
August 12, 2019
Importance of Natural History Studies to Rare Disease Drug Development
Read More
July 29, 2019
Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions
Read More
April 19, 2019
Cato Research Appoints Life Sciences Leader And Innovator To Executive Chairman
Read More
April 3, 2019
Pharm-Olam Wins 2019 CRO Leadership Awards
Read More
March 6, 2019
Celebrating 25-Year Anniversary and Enhanced Rare Disease Services
Read More
February 5, 2019
Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study
Read More
October 30, 2018
Orphan Trial leads to First Therapeutic for the Treatment for aTTP
Read More
October 24, 2018
Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos
Read More
July 31, 2018
Pharm-Olam Supports Clinical Trials and Sponsors Compliance with GDPR
Read More
April 27, 2018
Webinar: GDPR Implementation Across Global Clinical Trial Industry
Read More
January 11, 2018
Pharm-Olam LLC Appoints Dr. Kelly McKee as Chief Medical Officer
Read More
June 13, 2017
2017 Winner in CRO Leadership Awards for Second Consecutive Year
Read More
May 31, 2017
Pharm-Olam International Adds John Barry as Chief Operating Officer
Read More
March 23, 2017
Pharm-Olam Webinar: Evolution of Response Evaluation Oncology Trials
Read More
February 22, 2017
Pharm-Olam LLC Announces New Addition to Lead Biostatistics Team
Read More
February 9, 2017
Quad-C Management Announces Investment in Pharm-Olam LLC
Read More
January 31, 2017
Using Medidata Rave improves Data Management & Reporting Capabilities
Read More
November 16, 2016
Pharm-Olam adds New Addition to Quality and Compliance Leadership Team
Read More
November 1, 2016
Webinar: Global Clinical Research Leaders Address Rescue Study Challenges
Read More
October 25, 2016
Pharm-Olam Adds Director of Scientific Development
Read More
September 27, 2016
Pharm-Olam LLC Nominated for 2016 Scrip Awards Best Full-Service CRO
Read More
September 1, 2016
37th Telly Award Winner for Promotion of Allergy Clinical Research
Read More
August 17, 2016
Pharm-Olam Bolsters Client Outreach with Proposals and Contracts hire
Read More
June 27, 2016
Pharm-Olam International Strengthens Country Leadership with Strategic Hire in Mexico
Read More
May 24, 2016
Pharm-Olam International Adds Regional Director, Clinical Operations
Read More
May 10, 2016
Pharm-Olam International Awarded Six CRO Leadership Awards
Read More
January 12, 2016
Pharm-Olam Continues Global Expansion; Adds Full-Service Coverage in Asia-Pacific Region
Read More
December 20, 2015
Pharm-Olam Strengthens Leadership Team with New CFO
Read More
October 13, 2015
Pharm-Olam International Expands to Larger Facility in Poland
Read More
June 11, 2015
Pharm-Olam International Opens a New Office in Paris, France; Continues Global Expansion
Read More
March 12, 2015
Pharm-Olam's Case Study on Automated Sample Retention for BA/BE
Read More
February 12, 2015
Pharm-Olam: Phase III Pulmonary Arterial Hypertension study completed
Read More
January 12, 2015
Pharm-Olam releases a corporate overview video
Read More
November 13, 2014
Webinar: How political events are affecting clinical trials in Ukraine
Read More
November 4, 2014
Pharm-Olam International Celebrates 20-Year Anniversary
Read More
February 1, 2014
Pharm-Olam completes birch and grass pollen allergy studies
Read More
January 13, 2014
Pharm-Olam Expands into IsraelPharm-Olam is pleased to announce expansion into Israel. Incorporating Israel into your clinical trials offers you several benefits including:
Read More
May 30, 2013
Pharm-Olam expands Clinical Trial Services to Kazakhstan
Read More
No posts found